Overview
Neonatal neutropenia is a hematological condition characterized by an abnormally low number of neutrophils (a type of white blood cell essential for fighting bacterial and fungal infections) in newborn infants. Neutropenia in neonates is generally defined as an absolute neutrophil count (ANC) below 1,000–1,500 cells per microliter of blood, though reference ranges vary depending on gestational age and postnatal age. The condition primarily affects the immune system, leaving affected neonates vulnerable to serious and potentially life-threatening bacterial and fungal infections. Clinical manifestations may include fever, skin infections, omphalitis (infection of the umbilical stump), pneumonia, sepsis, and other localized or systemic infections. Neonatal neutropenia can arise from multiple etiologies. It may be alloimmune (caused by maternal antibodies directed against fetal neutrophil antigens, analogous to hemolytic disease of the newborn), autoimmune (associated with maternal autoimmune conditions), or secondary to maternal conditions such as pregnancy-induced hypertension or preeclampsia. It can also occur in the context of congenital or genetic forms of neutropenia, infections (bacterial or viral), necrotizing enterocolitis, or bone marrow suppression. Premature and low-birth-weight infants are particularly susceptible. Management depends on the underlying cause and severity. In many cases, neonatal neutropenia is transient and resolves spontaneously within days to weeks as the infant's bone marrow matures or as maternal antibodies are cleared. For infants with severe neutropenia and active or recurrent infections, treatment may include antibiotics, antifungal agents, and in some cases recombinant granulocyte colony-stimulating factor (G-CSF) to stimulate neutrophil production. Intravenous immunoglobulin (IVIG) may be considered in alloimmune cases. Close monitoring of blood counts and vigilant infection surveillance are essential components of care.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Neonatal neutropenia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Neonatal neutropenia at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Neonatal neutropenia.
Community
No community posts yet. Be the first to share your experience with Neonatal neutropenia.
Start the conversation →Latest news about Neonatal neutropenia
No recent news articles for Neonatal neutropenia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Neonatal neutropenia
What is Neonatal neutropenia?
Neonatal neutropenia is a hematological condition characterized by an abnormally low number of neutrophils (a type of white blood cell essential for fighting bacterial and fungal infections) in newborn infants. Neutropenia in neonates is generally defined as an absolute neutrophil count (ANC) below 1,000–1,500 cells per microliter of blood, though reference ranges vary depending on gestational age and postnatal age. The condition primarily affects the immune system, leaving affected neonates vulnerable to serious and potentially life-threatening bacterial and fungal infections. Clinical manife
At what age does Neonatal neutropenia typically begin?
Typical onset of Neonatal neutropenia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Neonatal neutropenia?
17 specialists and care centers treating Neonatal neutropenia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.